EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

From treatment to threat: the fatal impact of cumulative glucocorticoid dosage on outcomes in immunocompromised patients with community-acquired pneumonia

Saibin Wang iD, Qian Ye, Yijun Sheng

Therapeutic Advances in Respiratory Disease · 2025

DOI: 10.1177/17534666251332085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2025. Verfasst von Saibin Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang Province, China. Hauptthemen laut MEDLINE: Immunocompromised Host, Community-Acquired Infections, Glucocorticoids, Pneumonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Science and Technology Major Project of Jinhua City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic glucocorticoid therapy is known to heighten the risk of secondary pulmonary infections. However, the impact of cumulative glucocorticoid dosage (CGD) on mortality risk in patients who develop community-acquired pneumonia (CAP) while undergoing glucocorticoid therapy remains inadequately explored.

Objectives

This study aims to clarify the relationship between CGD and mortality outcomes in immunocompromised patients with CAP.

Design

This study is a retrospective cohort analysis utilizing data from the DRYAD database.

Methods

We examined data from 561 patients diagnosed with CAP who had received either oral or intravenous glucocorticoids prior to their CAP diagnosis. To evaluate the effect of CGD on mortality risk, we employed piecewise linear regression and Cox regression analyses, adjusting for relevant confounders.

Results

Among the study population, the median CGD was 4 g of methylprednisolone (interquartile range 2.16–8.80 g). The 30-, 60-, and 90-day mortality rates were 22.28%, 25.13%, and 25.49%, respectively. Piecewise linear regression analysis revealed a nonlinear relationship between methylprednisolone dose and mortality risk, indicating a threshold effect at a methylprednisolone level of 20 g. In addition, Cox regression analysis showed a significantly higher mortality risk in patients with CGD exceeding 40 g of methylprednisolone compared to those with CGD between 20 and 40 g, after adjusting for potential confounding factors (adjusted HR 5.16, 95% CI: 1.16–22.99, p < 0.05).

Conclusion

CAP occurring in close proximity to recent high doses of steroids is associated with pathogens typically seen in immunocompromised hosts and is linked to higher mortality compared to usual CAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostCommunity-Acquired InfectionsGlucocorticoidsPneumoniaMethylprednisoloneHumansRetrospective StudiesMaleFemaleMiddle AgedAgedDose-Response Relationship, DrugRisk FactorsDatabases, FactualTreatment OutcomeAdministration, OralTime FactorsAdultCommunity-Acquired Pneumonia

Stichwörter der Autor:innen

community-acquired pneumoniaglucocorticoidsimmunosuppressionmortalitythreshold effect

Substanzen

GlucocorticoidsMethylprednisolone

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang Province, China.
  • School of Medicine, Shaoxing University, Shaoxing, Zhejiang Province, China.
  • Department of Medical Records Quality Management, Jinhua Municipal Central Hospital, Jinhua, Zhejiang Province, China.
  • Department of Pulmonary and Critical Care Medicine, Jinhua Municipal Central Hospital, No. 365, East Renmin Road, Jinhua 321000, Zhejiang Province, China.

ORCID-Profile: Saibin Wang

Förderung

  • the Science and Technology Major Project of Jinhua City

Zitieren

APA

Wang, S., Ye, Q., & Sheng, Y. (2025). From treatment to threat: the fatal impact of cumulative glucocorticoid dosage on outcomes in immunocompromised patients with community-acquired pneumonia. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666251332085

Vancouver

Wang S, Ye Q, Sheng Y. From treatment to threat: the fatal impact of cumulative glucocorticoid dosage on outcomes in immunocompromised patients with community-acquired pneumonia. Therapeutic Advances in Respiratory Disease. 2025. doi:10.1177/17534666251332085

BibTeX
@article{Wang2025,
  author = {Wang, Saibin and Ye, Qian and Sheng, Yijun},
  title = {From treatment to threat: the fatal impact of cumulative glucocorticoid dosage on outcomes in immunocompromised patients with community-acquired pneumonia},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2025},
  doi = {10.1177/17534666251332085}
}
Kostenlos starten →